These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7104221)

  • 1. Hormonal treatment of impetigo herpetiformis.
    Gligora M; Kolacio Z
    Br J Dermatol; 1982 Aug; 107(2):253. PubMed ID: 7104221
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of the immune status of patients with dysfunctional uterine hemorrhages during treatment with female sex hormones].
    Mitrofanov NA; Golovistikov IN; Rotkina IE
    Akush Ginekol (Mosk); 1984 Feb; (2):71-2. PubMed ID: 6721081
    [No Abstract]   [Full Text] [Related]  

  • 3. [The treatment of meno-metrorrhagia of functional origin by an estro-progestational compound: ethynodiol diacetate combined with mestranol].
    Dumont M; Thoulon JM
    Lyon Med; 1967 Jun; 217(25):1847-52. PubMed ID: 5610232
    [No Abstract]   [Full Text] [Related]  

  • 4. [Endocervical epithelial changes in internal uterine endometriosis treated with bisekurin].
    Sabsaĭ MI; Kravchuk TA
    Akush Ginekol (Mosk); 1980 Oct; (10):43-4. PubMed ID: 7446855
    [No Abstract]   [Full Text] [Related]  

  • 5. Experience with ethynodiol diacetate and mestranol as an oral contraceptive.
    Gidwani GP; Purandare BN
    J Obstet Gynaecol India; 1968 Apr; 18(2):287-93. PubMed ID: 12331821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The problem of period control in disabled women.
    Hamilton EA; Nichols PJ
    Ann Phys Med; 1968 Aug; 9(7):288-94. PubMed ID: 4234086
    [No Abstract]   [Full Text] [Related]  

  • 7. Aspects of a new oral contraceptive, Ovulen.
    Dahlberg B
    Acta Obstet Gynecol Scand; 1966; 45(S9):43-6. PubMed ID: 5958397
    [No Abstract]   [Full Text] [Related]  

  • 8. [1st results with the ethynodiol diacetate-mestranol combination].
    Mancuso S
    Minerva Ginecol; 1966 Apr; 18(8):433-7. PubMed ID: 5920234
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experience with an estrogen-progestogen association with low estrogen content (ethinodiol-ethinylestradiol)].
    Andreoli C; Fiorentino F; Lenzi G
    Quad Clin Ostet Ginecol; 1970 Jan; 25(1):15-28. PubMed ID: 5523807
    [No Abstract]   [Full Text] [Related]  

  • 10. Endometriosis: treatment with hormonal pseudopregnancy and-or operation.
    Andrews WC; Larsen GD
    Am J Obstet Gynecol; 1974 Mar; 118(5):643-51. PubMed ID: 4813805
    [No Abstract]   [Full Text] [Related]  

  • 11. [Indications and treatment of menstrual disorders with a synthetic progestational hormone, ethynodiol diacetate alone or combined in variable doses with an estrogen].
    Soutoul JH
    Rev Fr Gynecol Obstet; 1969; 64(1):41-55. PubMed ID: 5362109
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of synthetic steroid preparations for hemostasis and normalization of menstrual function in juvenile hemorrhages].
    Kuznetsova MN; Antipina NN; Zagorskaia EA
    Vopr Okhr Materin Det; 1978 Feb; 23(2):77-80. PubMed ID: 347706
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cytologic and colposcopic findings before and after administration of ovulation inhibitors].
    Loskant G; Heinen G
    Zentralbl Gynakol; 1968 May; 90(18):609-13. PubMed ID: 5722983
    [No Abstract]   [Full Text] [Related]  

  • 14. [FH 027 in the treatment of dysmenorrhea].
    Kolenc M
    Bord Med; 1970 May; 3(5):1409-10. PubMed ID: 5425890
    [No Abstract]   [Full Text] [Related]  

  • 15. [Induction of uterine hemorrhage using 17-alpha-ethynyl-4-estrene-3-beta, 17-beta-diol diacetate (ethynodiol diacetate)].
    Tanaka Y
    Sanfujinka No Jissai; 1969 Feb; 18(2):185-7. PubMed ID: 5818867
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ovulen, its effect on the endometrium, uterine cervix and ovary].
    Muller G; Dehalleux JM; Ritter J; Philippe E; Gandar R
    Gynecol Obstet (Paris); 1968; 67(5):521-32. PubMed ID: 5730661
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ovulen in the treatment of the premenstrual syndromes in psychiatric patients].
    Rasmussen R; Hagen A; Ravn J
    Ugeskr Laeger; 1967 Feb; 129(7):224-6. PubMed ID: 5599219
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the mechanisms underlying carbohydrate intolerance in subclinical diabetic women during pregnancy and during post-partum oral contraceptive steroid treatment.
    Beck P; Wells SA
    J Clin Endocrinol Metab; 1969 Jun; 29(6):807-18. PubMed ID: 4978229
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical trials of a low-dose inhibitor of ovulation].
    Poiret C; Picavet B
    Lille Med; 1970 May; ():Suppl 4:737-9. PubMed ID: 5428132
    [No Abstract]   [Full Text] [Related]  

  • 20. [Our clinical experience with ethynodiol diacetate, alone or combined in variable doses with mestranol].
    Colin R
    Gynecol Obstet (Paris); 1966; 65(4):537-43. PubMed ID: 5971381
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.